ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 634353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 634353; 2) Community: the network communities that were significantly associated with the response to NSC 634353; 3) Molecule: the relationships between components within communities and NSC 634353; 4) MDR: the compounds that were significantly associated with the NSC 634353.

NSC Compound Enrichment Correlation
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.0478540623811426 0.17365215
NSC 666160 Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) 0.0478540623811426 0.30832882
NSC 667049 2-ethenyl estradiol 0.0478540623811426 0.24426239
NSC 667876 Null 0.0478540623811426 0.35521327
NSC 668324 Null 0.0478540623811426 0.59790075
NSC 671043 2-Ethoxyestra-1,3,5-trien-3,17.beta.-diol 0.0478540623811426 0.2789932
NSC 673182 Null 0.0478540623811426 0.54482368
NSC 680935 2H-Furo[3',2':3,4]benzopyrano[6,7-b]pyridine- 2,6,11-trione, 2,3-dihydro-5,5,8-trimethyl- 0.0478540623811426 0.6018494
NSC 681640 Camptothecin Derivative 0.0478540623811426 0.21410674
NSC 681642 Camptothecin Derivative 0.0478540623811426 0.28090008
Total:149  Current:145    [First] [Prev] [Next] [Last]